Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure (Q40574551)
Jump to navigation
Jump to search
scientific article published on May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure |
scientific article published on May 2004 |
Statements
1 reference
Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure (English)
1 reference
Baoqing Guo
1 reference
David J Villeneuve
1 reference
Stacey L Hembruff
1 reference
Angie F Kirwan
1 reference
David E Blais
1 reference
Michel Bonin
1 reference
Amadeo M Parissenti
1 reference
1 May 2004
1 reference
1 reference
85
1 reference
1
1 reference
31-51
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference